The genetic disorder, prcd-PRA , causes cells in the retina at the back of
the eye to degenerate and die, even though the cells seem to develop normally early in life. The “rod” cells
operate in low light levels and are the first to lose normal function. Night blindness results. Then the “cone”
cells gradually lose their normal function in full light situations. Most affected dogs will eventually be blind. Typically,
the clinical disease is recognized first in early adolescence or early adulthood. Since age at onset of disease varies among
breeds, you should read specific information for your dog. Diagnosis of retinal disease can be difficult. Conditions that
seem to be prcd-PRA might instead be another disease and might not be inherited. OptiGen’s genetic test assists
in making the diagnosis. It’s important to remember that not all retinal disease is PRA and not all PRA is the prcd
form of PRA. Annual eye exams by a veterinary ophthalmologist will build a history of eye health that will help to diagnose
disease.
Prcd-PRA
is inherited as a recessive trait. This means a disease gene must be inherited from each parent in order to cause disease
in an offspring. Parents were either “carrier” or affected. A carrier has one disease gene and one normal gene,
and is termed “heterozygous” for the disease. A normal dog has no disease gene and is termed “homozygous
normal” – both copies of the gene are the same. And a dog with two disease genes is termed “homozygous affected”
– both copies of the gene are abnormal.
It’s
been proven that all breeds being tested for prcd-PRA have the same disease caused by the same mutated gene. This
is so, even though the disease might develop at different ages or with differing severity from one breed to another.
Although prcd-PRA is
inherited, it can be avoided in future generations by testing dogs before breeding. Identification of dogs that do not carry
disease genes is the key. These "clear" dogs can be bred to any mate - even to a prcd-affected dog which
may be a desirable breeding prospect for other reasons. The chance of producing affected pups from such breedings depends
on the certainty of test results. Again, you’ll find the specific information on certainty of test results for your
dog by linking to breed specific information.
The Genetic Test
The OptiGen prcd test is done on a small sample of blood from the dog. The test analyzes
the specific DNA mutation causing prcd-PRA. The OptiGen test detects the mutant, abnormal gene copy and the normal gene copy.
The result of the test is a genotype and allows separation of dogs into three groups: Normal/Clear (homozygous normal), Carrier
(heterozygous) and Affected (homozygous mutant).
Possible results using the OptiGen prcd test |
Genotype | Risk Group | Significance For Breeding | Risk of prcd Disease |
Homozygous Normal | Normal/Clear | Can be bred to any dog, extremely low risk
of producing affecteds | Extremely
low |
Heterozygous | Carrier | Should be bred only to Normal/ Clear to remove risk of producing
affecteds | Extremely
low |
Homozygous Mutant | Affected | Should be bred only to Normal/ Clear to remove risk of producing affecteds | Very
high |